Published in Arch Environ Health on December 03, 1976
The aging process. Proc Natl Acad Sci U S A (1981) 4.66
Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst (2014) 1.44
Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial. Head Face Med (2006) 1.28
Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res (2006) 1.05
Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr (2007) 1.05
Effects of antioxidants on oxidant-induced sister chromatid exchange formation. J Clin Invest (1985) 0.99
Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc Natl Acad Sci U S A (1986) 0.97
Metal interactions in carcinogenesis: enhancement, inhibition. Environ Health Perspect (1981) 0.95
Immunological and biochemical markers in oral carcinogenesis: the public health perspective. Int J Environ Res Public Health (2008) 0.93
Toxic interactions among environmental pollutants: corroborating laboratory observations with human experience. Environ Health Perspect (1994) 0.85
Clinical Correlation between Gastric Cancer Type and Serum Selenium and Zinc Levels. J Gastric Cancer (2012) 0.85
Nutraceuticals in Prostate Disease: The Urologist's Role. Rev Urol (2008) 0.83
Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2013) 0.81
Protective effect of selenium on lung cancer in smelter workers. Br J Ind Med (1985) 0.80
Association of selenium status and blood glutathione concentrations in blacks and whites. Nutr Cancer (2011) 0.80
Selenium and cancer. BMJ (1988) 0.76
The Serum Levels of Trace Metals in Nigerian Males with Different PSA Values. Malays J Med Sci (2008) 0.75
Performance evaluation of computed radiography systems. Med Phys (2001) 1.41
Characterization of monochrome CRT display systems in the field. J Digit Imaging (1999) 1.34
Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr (1980) 1.26
Preliminary assessment of computed tomography and satellite teleradiology from Operation Desert Storm. Invest Radiol (1991) 1.22
Possible protective effect of selenium against human cancer. Can Med Assoc J (1969) 1.22
Selenium distribution and human cancer mortality. CRC Crit Rev Clin Lab Sci (1971) 1.20
Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J Natl Cancer Inst (1970) 1.17
Neonatal hypernatremic dehydration associated with breast-feeding malnutrition: a retrospective survey. CMAJ (2000) 1.11
The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells. Lipids (1984) 1.03
Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem (1984) 1.02
Antioxidants in cereals and in food preservatives and declining gastric cancer mortality. Cleve Clin Q (1972) 0.94
Increase of peroxidation in carcinogenesis. J Natl Cancer Inst (1972) 0.94
Staphylococcus aureus and sore nipples. Can Fam Physician (1996) 0.93
Infant insufficient milk syndrome associated with maternal postpartum hemorrhage. J Hum Lact (1995) 0.93
Purification and properties of cathepsin D from bovine utrus. J Biol Chem (1971) 0.93
Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. J Natl Cancer Inst (1974) 0.92
Antioxidants reduce the mutagenic effect of malonaldehyde and beta-propiolactone. Part IX. Antioxidants and cancer. Mutat Res (1979) 0.90
Increase of lysosomal enzymes in skin cancers. Nature (1967) 0.85
Carcinogen-induced chromosomal breakage decreased by antioxidants. Proc Natl Acad Sci U S A (1973) 0.85
Lysosomal and nonlysosomal enzyme activities of Morris hepatomas. Cancer Res (1971) 0.84
The genotoxicity of selenium. Mutat Res (1985) 0.83
Genetic toxicology of ascorbic acid. Mutat Res (1984) 0.83
Protection against cocarcinogenesis by antioxidants. Experientia (1966) 0.83
Enzymatic determination of plasma ammonia: evaluation of Sigma and BMC Kits. Clin Chem (1978) 0.83
Methods compared for determining zinc in serum by flame atomic absorption spectroscopy. Clin Chem (1978) 0.83
Selenium in the drinking water and cardiovascular disease. J Environ Pathol Toxicol (1980) 0.82
Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J Natl Cancer Inst (1973) 0.81
Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells. Mol Pharmacol (1982) 0.80
Malonaldehyde content of food. J Nutr (1977) 0.79
The potential value of red cell transketolase in the metabolic evaluation of disease. Cleve Clin Q (1978) 0.77
Selenium metabolism and function. Clin Physiol Biochem (1986) 0.77
Evaluation of the biochemical effects of administration of intravenous nutrients using erythrocyte ATP/ADP ratios. Altern Med Rev (1999) 0.76
Selenium in the environment. Sci Total Environ (1981) 0.76
Effect of protein depletion and repletion on liver structures, nitrogen content and serum proteins. Ann Surg (1979) 0.75
Lysosomal enzyme changes in growing and regressing mammary tumours. Biochem J (1969) 0.75
The coma profile. Cleve Clin Q (1973) 0.75
Letter: Polyunsaturates and cancer. Med J Aust (1976) 0.75
Maple syrup urine disease variant. Report of a case. Cleve Clin Q (1972) 0.75
Cyanmethemoglobin certification program of the College of American Pathologists. Am J Clin Pathol (1970) 0.75
Lactate dehydrogenase isoenzyme 1 as determined by inhibition with 1,6-hexanediol and by two other methods in patients with myocardial infarction or cardiac-bypass surgery. Clin Chem (1987) 0.75
High pressure liquid chromatography for simultaneous analysis of anticonvulsants: comparison with EMIT system. Ther Drug Monit (1979) 0.75
Evaluation of water soluble and lipid soluble sialic acid levels as tumor markers. Anticancer Res (1986) 0.75
Reduced benzo(a)pyrene and phenolic content of smoke from experimental cigarettes. Nature (1966) 0.75
Effects of blood and urine on lead analyzed by flameless atomic absorption. J Clin Chem Clin Biochem (1983) 0.75
Is selenium a teratogen? Lancet (1971) 0.75
Relationship of physical factors to the inertness of lysosomal hydrolases toward one another. Experientia (1969) 0.75
Trace metal analysis. Cancer Invest (1985) 0.75
Serum lysozyme and inflammatory bowel disease. Cleve Clin J Med (1987) 0.75
Inhibitory effect of vitamin A on carcinogenesis. J Natl Cancer Inst (1971) 0.75